Business of regenerative medicine: preservation and the supply chain
Join our international panel for part three of their discussion.
In the third part of our expert panel on the business of regenerative medicine, learn more about the challenges of designing suitable preservation processes and integrating these into a supply chain.
Plus, our panelists share their predictions for the future of regenerative medicine.
Chaired by Michael May, CCRM, this panel discussion focuses on the key business challenges within regenerative medicine. Joining Michael were four leading voices in regenerative medicine and cell therapy, from research to manufacture: Robert Preti (Hitachi Chemical Advanced Therapeutics Solutions, LLC), Robert Jones (Fisher Bioservices), Carolyn Yeago (Georgia Institute of Technology) and Qasim Rafiq (UCL).